NCT02452060View on ClinicalTrials.gov

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 13, 2017

Study Completion Date

April 13, 2017

Conditions
PainPostoperative Depression
Interventions
DRUG

Ketamine

0.4mg/kg infusion

OTHER

Placebo Comparator

0.4mg/kg infusion

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02452060 - Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy | Biotech Hunter | Biotech Hunter